Understanding the rise of cardiometabolic diseases in low- and middle-income countries

Nat Med. 2019 Nov;25(11):1667-1679. doi: 10.1038/s41591-019-0644-7. Epub 2019 Nov 7.

Abstract

Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Developing Countries
  • Diabetes Mellitus / epidemiology*
  • Diabetes Mellitus / metabolism
  • Diabetes Mellitus / pathology
  • Health Policy
  • Humans
  • Metabolic Diseases / epidemiology*
  • Metabolic Diseases / metabolism
  • Metabolic Diseases / pathology
  • Risk Factors